CD4 c.239C>T ;(p.A80V)

Variant ID: 12-6923332-C-T

NM_000616.4(CD4):c.239C>T;(p.A80V)

This variant was identified in 3 publications

View GRCh38 version.




Publications:


Potential Resistance of SARS-CoV-2 Main Protease (Mpro) against Protease Inhibitors: Lessons Learned from HIV-1 Protease.

International Journal Of Molecular Sciences
Mótyán, János András JA; Mahdi, Mohamed M; Hoffka, Gyula G; Tőzsér, József J
Publication Date: 2022-03-23

Variant appearance in text: CD4: A80V
PubMed Link: 35408866
Variant Present in the following documents:
  • ijms-23-03507.pdf
View BVdb publication page



HIV-1 acquired drug resistance to integrase inhibitors in a cohort of antiretroviral therapy multi-experienced Mexican patients failing to raltegravir: a cross-sectional study.

Aids Research And Therapy
Orta-Resendiz, Aurelio A; Rodriguez-Diaz, Roberto A RA; Angulo-Medina, Luis A LA; Hernandez-Flores, Mario M; Soto-Ramirez, Luis E LE
Publication Date: 2020-02-10

Variant appearance in text: CD4: A80V
PubMed Link: 32041622
Variant Present in the following documents:
  • Main text
  • 12981_2020_Article_262.pdf
View BVdb publication page



Recurrent and Prolonged Infections in a Child with a Homozygous IFIH1 Nonsense Mutation.

Frontiers In Genetics
Zaki, Maha M; Thoenes, Michaela M; Kawalia, Amit A; Nürnberg, Peter P; Kaiser, Rolf R; Heller, Raoul R; Bolz, Hanno J HJ
Publication Date: 2017

Variant appearance in text: CD4: 239C>T
PubMed Link: 29018476
Variant Present in the following documents:
View BVdb publication page